ASX Share rice
Thu 13 Aug 2020 - 09:56:am (Sydney)

PAL Share Price

PALLA PHARMA LIMITEDPALPharmaceuticals, Biotechnology & Life Sciences

PAL Company Information

Name:

Palla Pharma Limited

Sector:

Consumer Goods

Industry:

Farm Products

Address:

Tower 4 Docklands VIC Australia 3008

Phone:

61 3 9301 0800

Founder, MD, CEO & Exec. Director:

Mr. Jarrod David Ritchie B.Sc., BSc (Hons)

Chief Financial Officer:

Mr. Brendan Middleton

Company Sec.:

Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA

Company Overview:

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. The company was founded in 2004 and is based in Docklands, Australia.

PAL Share Price Information

Shares Issued:

125.95M

Market Capitalisation:

$106.43M

Revenue (TTM):

$54.69M

Revenue Per Share (TTM):

$0.62

Earnings per Share:

$-0.087

Profit Margin:

-0.1397

Operating Margin (TTM):

$-0.05

Return On Assets (TTM):

$-0.02

Return On Equity (TTM):

$-0.13

Quarterly Revenue Growth (YOY):

0.153

Gross Profit(TTM):

$17.30M

Diluted Earnings Per Share (TTM):

$-0.087

PAL CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-2,476,307

Change To Liabilities:

$-1,701,685

Total Cashflow From Investing Activities:

$-2,476,307

Net Borrowings:

$-17,401,610

Net Income:

$-7,639,443

Total Cash From Operating Activities:

$-9,469,268

Depreciation:

$2.51M

Change To Inventory:

$-3,411,722

Change To Account Receivables:

$-2,025,329

Sale Purchase Of Stock:

$-1,888,738

Capital Expenditures:

$2.49M

PAL Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-7,777,636

Net Income:

$-7,639,443

Gross Profit:

$25.52M

Operating Income:

$-2,825,637

Other Operating Expenses:

$1.81M

Interest Expense:

$3.11M

Income Tax Expense:

$-138,193

Total Revenue:

$54.69M

Total Operating Expenses:

$28.34M

Cost Of Revenue:

$29.17M

PAL Balance Sheet

Balance Sheet Date:

2019-12-31

Intangible Assets:

$3.01M

Total Liabilities:

$18.16M

Total Stockholder Equity:

$71.41M

Other Current Liabilities:

$890.90K

Total Assets:

$89.57M

Common Stock:

$211M

Other Current Assets:

$6M

Retained Earnings:

$-143,182,411

Other Liabilities:

$1.94M

Good Will:

$13.96M

Other Assets:

$3.46M

Cash:

$2.02M

Total Current Liabilities:

$11.22M

Short-Term Debt:

$467.42K

Property - Plant & Equipment:

$26.69M

Net Tangible Assets:

$55.24M

Long-Term Investments:

$103.27K

Total Current Assets:

$43.15M

Long-Term Debt:

$5M

Net Receivables:

$11.27M

Short-Term Investments:

$46.42M

Inventory:

$22.15M

Accounts Payable:

$7.04M

Non Currrent Assets (Other):

$2.25M

Short-Term Investments:

$46.42

Non Current Liabilities Total:

$6.94M

PAL Share Price History

PAL News

17 Jul, 2020
It is a pleasure to report that the Palla Pharma Limited (ASX:PAL) is up 37% in the last quarter. Meanwhile over the...
27 Apr, 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
25 Jan, 2020
The CEO of Palla Pharma Limited (ASX:PAL) is Jarrod Ritchie. This analysis aims first to contrast CEO compensation...
11 Dec, 2019
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the last three...
04 Oct, 2019
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...